 The EZ-REED platform is a new technology that allows for the detection of rare RNA molecules in blood samples. This technology uses hybrid complexes composed of protein enzymes and metal organic frameworks to create a strong catalytic reaction that can be used to detect specific RNA molecules. This platform can also be used to accurately diagnose and subtype glioblastoma, the most aggressive form of brain cancer. This article was authored by Yang Zhong, Kai Yang Wang, Kareen Z, J Lim, and others.